Articles of Association EGM

RNS Number : 0881D

Advanced Medical Solutions Grp PLC

10 September 2008

 



For immediate release

10 September 2008

Advanced Medical Solutions Group plc

('AMS' or 'the Group')

Extraordinary General Meeting to adopt new Articles of Association

AMS has posted to shareholders a Circular containing notice of an Extraordinary General Meeting ('EGM') of AMS to be held at 10.00 am on 3 October 2008 at AMS's registered office at Road Three Industrial Estate, Winsford, Cheshire CW7 3PD, at which a resolution will be proposed to approve and adopt 'New Articles A' and 'New Articles B' in substitution for, and to the exclusion of, the existing Articles of Association, with immediate effect and with effect from 1 October 2009 respectively.

There have been a number of recent changes to company law as a result of the implementation of the Companies Act 2006. Shareholders are therefore being asked to approve and adopt New Articles A and New Articles B to reflect certain of those changes.  

The Circular sets out the background to the proposals and further details on them. Copies of the Circular are available for inspection at AMS's registered office at Road Three Industrial Estate, Winsford, Cheshire CW7 3PD and at the offices of Wragge & Co LLP at 3 Waterhouse Square, 142 Holborn, London EC1N 2SW from today until the time of the EGM.

For further information, please contact:

Advanced Medical Solutions Group plc	[phone]
Don Evans, Chief Executive Officer
Mary Tavener, Group Finance Director
www.admedsol.com
Buchanan Communications	[phone]
Mark Court / Mary-Jane Johnson / Stasa Filiplic
Landsbanki Securities (UK) Ltd Shaun Dobson, Claes Spang	[phone]

Notes to Editors:

Advanced Medical Solutions is a leading company in the development and manufacture of products for the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative and technologically advanced woundcare products.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. AMS has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.

The acquisition of 49.4% of Corpura BV in May 2008 strengthened AMS' position in hydrophilic polyurethane foam - the largest and fastest growing segment of the advanced woundcare market

AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.

 

END

 

 

MSCFGGGLVLRGRZM